Stockreport

Roche Falters In A Key Breast Cancer Readout [Seeking Alpha]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Giredestrant remains on track for approval in other indications, supported by positive evERA and lidERA trial results in breast cancer. While the failed trial may tem [Read more]